Victrix Investment Advisors Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Victrix Investment Advisors acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,316 shares of the healthcare conglomerate's stock, valued at approximately $2,689,000. UnitedHealth Group makes up 1.9% of Victrix Investment Advisors' investment portfolio, making the stock its 20th largest position.

Other institutional investors and hedge funds also recently bought and sold shares of the company. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $28,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $30,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 6.2%

NYSE UNH opened at $291.24 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $264.20 billion, a PE ratio of 18.79, a PEG ratio of 1.37 and a beta of 0.56. The company's 50-day moving average price is $470.82 and its 200-day moving average price is $513.25. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the firm earned $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.88%. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders purchased 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on UNH shares. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday. Raymond James cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research report on Thursday. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Finally, HSBC reaffirmed a "hold" rating and issued a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Six equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $486.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.